Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV)

CUSIP: 92539P101

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
89,600,000
Total 13F shares
75,254,197
Share change
-1,372,601
Total reported value
$364,246,240
Put/Call ratio
247%
Price per share
$4.84
Number of holders
169
Value change
-$6,877,085
Number of buys
89
Number of sells
67

Quarterly Holders Quick Answers

What is CUSIP 92539P101?
CUSIP 92539P101 identifies VERV - Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of VERV - Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV) as of Q3 2024

As of 30 Sep 2024, Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV) was held by 169 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 75,254,197 shares. The largest 10 holders included Alphabet Inc., BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, VANGUARD GROUP INC, Casdin Capital, LLC, T. Rowe Price Investment Management, Inc., Schonfeld Strategic Advisors LLC, Novo Holdings A/S, and ARCH Venture Management, LLC. This page lists 169 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
161
Q3 2024 holders
169
Holder diff
8
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .